Xenon Pharmaceuticals Inc. (XENE)
NASDAQ: XENE · Real-Time Price · USD
28.99
-0.05 (-0.17%)
May 30, 2025, 3:31 PM - Market open
Xenon Pharmaceuticals Employees
As of December 31, 2024, Xenon Pharmaceuticals had 327 total employees, including 316 full-time and 11 part-time employees. The number of employees increased by 68 or 26.25% compared to the previous year.
Employees
327
Change (1Y)
68
Growth (1Y)
26.25%
Revenue / Employee
$22,936
Profits / Employee
-$768,948
Market Cap
2.22B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AbbVie | 55,000 |
XENE News
- 15 days ago - Xenon MRI Featured Prominently at ATS 2025 Across Broad Clinical Spectrum - GlobeNewsWire
- 15 days ago - Xenon to Present at the 2025 RBC Capital Markets Global Healthcare Conference - GlobeNewsWire
- 17 days ago - Xenon Pharmaceuticals Inc. (XENE) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 17 days ago - Xenon Reports First Quarter 2025 Financial Results and Provides Business Update - GlobeNewsWire
- 24 days ago - Xenon to Report Q1 2025 Financial Results on May 12, 2025 - GlobeNewsWire
- 27 days ago - Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 6 weeks ago - Xenon- A Later Stage Story - Seeking Alpha
- 7 weeks ago - Xenon Pharmaceuticals Looks Attractive Before Epilepsy Data - Seeking Alpha